U-Tryp (Ulinastatin) 100,000 I.U.
U-Tryp (Ulinastatin 100,000 I.U.) is a proteolytic enzyme inhibitor used for critical care management.
Manufacturer: Bharat Serums And Vaccines (India). It acts as a systemic anti-inflammatory agent.
Mechanism of Action ("Enzyme Blockade"):
In conditions like pancreatitis or sepsis, the body releases an excessive storm of enzymes (like trypsin and elastase) that damage healthy tissues. Ulinastatin binds to these enzymes and inhibits their activity. It effectively stops the "autodigestion" of the pancreas and reduces systemic inflammatory response syndrome (SIRS).
β Key Benefit: Rapid control of acute inflammation, pain relief in pancreatitis, and protection against organ failure.
Indicated for acute and severe conditions:
- π₯ Acute Pancreatitis: Treats the inflammation and prevents tissue necrosis.
- π₯ Chronic Pancreatitis: During acute exacerbations.
- π©Έ Sepsis and Severe Burns: Used to manage the systemic inflammatory response.
- Major surgery complications prevention.
Packaging: 4 ml Vial (Liquid form, 100,000 I.U.).
β οΈ ADMINISTRATION PROTOCOL:
- π IV Infusion Only: Never administer intramuscularly.
- β DILUTION MANDATORY: As stated on the box ("Do not inject undiluted"), the content must be mixed with 5% Dextrose or Normal Saline before infusion.
- π Standard Dose: Typically 100,000 to 200,000 I.U. per cycle, administered 1 to 3 times daily via slow intravenous drip (over 1-2 hours).
- Hypersensitivity to Ulinastatin or protein preparations.
- Pregnancy and breastfeeding (safety has not been established).
- Severe bleeding disorders.
Potential side effects to monitor:
- π€’ Gastrointestinal: Nausea or vomiting.
- π‘οΈ Allergic reactions: Itching, rash, or redness at the injection site.
- Temporary elevation of liver enzymes (AST/ALT).
What Customers Say
No reviews yet
Your review can be the first!